Currently a Professor in Pharmaceutics at the School of Pharmacy as University College Cork. Having completed his BSc. Pharm. degree at the School of Pharmacy in Trinity College Dublin (TCD), he proceeded to a PhD. in the Pharmaceutics at TCD. After working in pharmaceutical industry for a number of years (at Élan and Servier), he returned to academia in 2005. He is also Course Director of the MSc in Pharmaceutical Technology and Quality Systems, an on line masters course designed to train graduates working in the pharmaceutical industry to become a Qualified Person (QP). Dr. Griffin research interests focus on the development of optimised and targeted drug delivery systems. This includes lipid based formulations for enhancing oral bioavailability of poorly soluble drug compounds; design of nanoparticulate based drug delivery systems; targeted drug delivery to the brain and to the intestinal lymphatics. He continues to interact closely with the pharmaceutical industry and has a number of research collaborations with industrial partners. Dr. Griffin currently coordinates the 'InPharma’ EU research grant (https://www.inpharma-network.eu/). InPharma is a European Industrial Doctorate programme funded under the EU Horizon 2020 research and innovation programme (Marie Sklodowska-Curie actions). The InPharma consortium aims at eliminating animals from the development of oral drug formulations by substituting them with computational and bio-predictive in vitro tools. InPharma will apply an ‘end-to-end’ model-based drug development approach, by linking data emerging from drug discovery into computational models that predict the optimal formulation design, which is then integrated into models that predicting drug levels in simulated humans clinical trials.